Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Parkinson's Disease

  Free Subscription


1 BMC Neurol
2 Mov Disord
1 Nat Rev Neurol
1 Nature
1 Neurobiol Dis
3 Neurology
1 Proc Natl Acad Sci U S A
2 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. GEORGE P, Roushdy T, Fathy M, Hamid E, et al
    The clinical and neuroimaging differences between vascular parkinsonism and Parkinson's disease: a case-control study.
    BMC Neurol. 2024;24:56.
    PubMed         Abstract available

    Mov Disord

  2. WEINTRAUB D, Marras C, Amara A, Anderson KE, et al
    Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease.
    Mov Disord. 2024 Feb 6. doi: 10.1002/mds.29725.
    PubMed         Abstract available

  3. KULCSAROVA K, Skorvanek M
    Challenges and Future of the International Parkinson and Movement Disorder Society Prodromal Parkinson's Disease Criteria: Are We On the Right Track?
    Mov Disord. 2024 Feb 4. doi: 10.1002/mds.29724.

    Nat Rev Neurol

  4. WOOD H
    Extracellular vesicle alpha-synuclein marks PD risk.
    Nat Rev Neurol. 2024;20:63.


    Obesity drugs have another superpower: taming inflammation.
    Nature. 2024;626:246.

    Neurobiol Dis

  6. STOLL AC, Kemp CJ, Patterson JR, Howe JW, et al
    Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
    Neurobiol Dis. 2024;191:106411.
    PubMed         Abstract available


  7. PARNETTI L, Paoletti FP
    Fluid Biomarkers for Trial Enrichment and Effect Monitoring in Disease-Modifying Treatments for Parkinson Disease.
    Neurology. 2024;102:e209194.

  8. RAHAYEL S, Postuma R, Baril AA, Misic B, et al
    (99m)Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder.
    Neurology. 2024;102:e208015.
    PubMed         Abstract available

  9. HUTCHISON RM, Fraser K, Yang M, Fox T, et al
    Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
    Neurology. 2024;102:e209137.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  10. RONTGEN A, Toprakcioglu Z, Tomkins JE, Vendruscolo M, et al
    Modulation of alpha-synuclein in vitro aggregation kinetics by its alternative splice isoforms.
    Proc Natl Acad Sci U S A. 2024;121:e2313465121.
    PubMed         Abstract available

    Rev Neurol (Paris)

  11. CLEMENT G, Cavillon G, Vuillier F, Bouhaddi M, et al
    Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.
    Rev Neurol (Paris). 2024;180.
    PubMed         Abstract available

  12. PAVY-LE TRAON A, Foubert-Samier A, Fabbri M
    An overview on pure autonomic failure.
    Rev Neurol (Paris). 2024;180.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.